Search Results - "Darmon, A"

Refine Results
  1. 1

    A comparative study of non-thermal plasma assisted reforming technologies by Petitpas, G., Rollier, J.-D., Darmon, A., Gonzalez-Aguilar, J., Metkemeijer, R., Fulcheri, L.

    Published in International journal of hydrogen energy (01-09-2007)
    “…On board hydrogen production out of hydrocarbons (reforming) for fuel cells feed is subject to problems when used with traditional catalysts. High device…”
    Get full text
    Journal Article
  2. 2

    A specific prediction equation is necessary to estimate peak oxygen uptake in obese patients with metabolic syndrome by Debeaumont, D., Tardif, C., Folope, V., Castres, I., Lemaitre, F., Tourny, C., Dechelotte, P., Thill, C., Darmon, A., Coquart, J. B.

    Published in Journal of endocrinological investigation (01-06-2016)
    “…Purpose The aims were to: (1) compare peak oxygen uptake ( V ˙ O 2 peak) predicted from four standard equations to actual V ˙ O 2 peak measured from a…”
    Get full text
    Journal Article
  3. 3

    Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry by Darmon, A., Elbez, Y., Bhatt, D.L., Abtan, J., Mas, J.L., Cacoub, P., Montalescot, G., Billaut-Laden, I., Ducrocq, G., Steg, P.G.

    Published in Annales de cardiologie et d'angéiologie (01-10-2020)
    “…Following the publication of the COMPASS trial, the European Medicines Agency has approved a regimen of combination of rivaroxaban 2.5mg twice daily and a…”
    Get full text
    Journal Article
  4. 4

    Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B by Darmon, Alison J, Nicholson, Donald W, Bleackley, R. Chris

    Published in Nature (London) (05-10-1995)
    “…Cytotoxic T lymphocyte (CTL)-mediated cytotoxicity represents the body's major defence against virus-infected and tumorigenic cells, and contributes to…”
    Get full text
    Journal Article
  5. 5

    An atypical presentation of atherosclerosis in psoriasis: "Porcelain aorta" by Magis, Q, Carsuzaa, F, Flavian, A, Darmon, A, Grob, J-J, Richard, M-A

    “…Several recent epidemiological studies have shown an increase in cardiovascular morbidity and mortality in patients with psoriasis; such increase is greater in…”
    Get full text
    Journal Article
  6. 6

    Cloning and expression of a cDNA for the human prostanoid IP receptor by Boie, Y, Rushmore, T H, Darmon-Goodwin, A, Grygorczyk, R, Slipetz, D M, Metters, K M, Abramovitz, M

    Published in The Journal of biological chemistry (22-04-1994)
    “…A cDNA clone coding for a functional human prostanoid IP receptor has been isolated from a lung cDNA library. The human IP receptor consists of 386 amino acid…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B by Atkinson, E A, Barry, M, Darmon, A J, Shostak, I, Turner, P C, Moyer, R W, Bleackley, R C

    Published in The Journal of biological chemistry (14-08-1998)
    “…Cytototoxic T lymphocyte-induced apoptosis can occur either through the directed exocytosis of granzyme B and perforin or via ligation of Fas. Both pathways…”
    Get full text
    Journal Article
  9. 9

    The cytotoxic T cell proteinase granzyme B does not activate interleukin-1 beta-converting enzyme by Darmon, A J, Ehrman, N, Caputo, A, Fujinaga, J, Bleackley, R C

    Published in The Journal of biological chemistry (23-12-1994)
    “…Murine granzyme B (cytotoxic cell proteinase-1 (CCP1)) is a member of a family of seven serine proteases found in cytoplasmic granules of cytotoxic T…”
    Get full text
    Journal Article
  10. 10

    Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model by Zhang, Ping, Darmon, Audrey, Marill, Julie, Mohamed Anesary, Naeemunnisa, Paris, Sébastien

    Published in International journal of nanomedicine (01-01-2020)
    “…Despite tremendous results achieved by immune checkpoint inhibitors, most patients are not responders, mainly because of the lack of a pre-existing anti-tumor…”
    Get full text
    Journal Article
  11. 11

    NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models by Zhang, Ping, Marill, Julie, Darmon, Audrey, Mohamed Anesary, Naeemunnisa, Lu, Bo, Paris, Sébastien

    Published in International journal of nanomedicine (01-01-2021)
    “…The side effects of radiotherapy induced on healthy tissue limit its use. To overcome this issue and fully exploit the potential of radiotherapy to treat…”
    Get full text
    Journal Article
  12. 12

    P996Early experience of transnasal micro-transesophageal echocardiography to guide left atrium appendage closure under conscious sedation by Couture, E, Darmon, A, Stein, G, Platonov, I, Brennt, V, Horvilleur, J, Chevalier, B, Garot, P

    Published in European heart journal (01-10-2019)
    “…Abstract Introduction Percutaneous left atrial appendage closure (LAAC) is typically performed utilizing transesophageal echocardiography (TEE) and fluoroscopy…”
    Get full text
    Journal Article
  13. 13

    Waltzing route toward double-helix formation in cholesteric shells by Darmon, Alexandre, Benzaquen, Michael, Seč, David, Čopar, Simon, Dauchot, Olivier, Lopez-Leon, Teresa

    “…Liquid crystals, when confined to a spherical shell, offer fascinating possibilities for producing artificial mesoscopic atoms, which could then self-assemble…”
    Get full text
    Journal Article
  14. 14

    Comparison of Antithrombotic Regimens after Left Atrial Appendage Occlusion: A Systematic Review and Network Meta-analysis by Carvalho, P E P, Gewehr, D M, Miyawaki, I A, Nogueira, A, Felix, N, Nascimento, B R, Garot, P, Darmon, A, Mazzone, P, Preda, A, Kubrusly, L F, Cardoso, R

    Published in European heart journal (09-11-2023)
    “…Abstract Background The optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) in patients with non-valvular atrial fibrillation (AF)…”
    Get full text
    Journal Article
  15. 15

    Cleavage of CPP32 by Granzyme B Represents a Critical Role for Granzyme B in the Induction of Target Cell DNA Fragmentation by Darmon, A J, Ley, T J, Nicholson, D W, Bleackley, R C

    Published in The Journal of biological chemistry (06-09-1996)
    “…Cytotoxic T lymphocytes (CTLs) are able to recognize and destroy target cells bearing foreign antigen using one of two distinct mechanisms: granule- or…”
    Get full text
    Journal Article
  16. 16

    Different functions are required for initiation and maintenance of immortalization of rat embryo fibroblasts by SV40 large T antigen by POWELL, A. J, DARMON, A. J, GONOS, E. S, LAM, E. W.-F, PEDEN, K. W. C, JAT, P. S

    Published in Oncogene (02-12-1999)
    “…We have used two different, but complementary assays to characterize functions of SV40 T antigen that are necessary for its ability to immortalize rat embryo…”
    Get full text
    Journal Article
  17. 17
  18. 18

    P5010Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry by Darmon, A, Ducrocq, G, Jasliek, A, Feldman, L J, Sorbets, E, Ferrari, R, Ford, I, Tardif, J C, Tendera, M, Fox, K M, Steg, P G

    Published in European heart journal (01-10-2019)
    “…Abstract Background The COMPASS trial showed that a combination of rivaroxaban and aspirin improved cardiovascular (CV) outcomes in patients with stable…”
    Get full text
    Journal Article
  19. 19

    2211Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. an analysis from the CLARIFY registry by Darmon, A, Ducrocq, G, Elbez, Y, Sorbets, E, Ferrari, R, Ford, I, Tardif, J C, Tendera, M, Fox, K M, Steg, P G

    Published in European heart journal (01-10-2019)
    “…Abstract Background The prevalence, and prognostic implication of left bundle branch block (LBBB) in general population and patients admitted for acute…”
    Get full text
    Journal Article
  20. 20

    3294Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry by Darmon, A, Ducrocq, G, Jasilek, A, Juliard, J M, Sorbets, E, Ferrari, R, Ford, I, Tardif, J C, Fox, K M, Steg, P G

    Published in European heart journal (01-10-2019)
    “…Abstract Background The COMPASS trial demonstrated that a combination of rivaroxaban and aspirin improved cardiovascular (CV) outcomes in high-risk patients…”
    Get full text
    Journal Article